World Journal of Gastroenterology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Yamada K, Sawada T, Nakamura M, Yamamura T, Maeda K, Ishikawa E, Iida T, Mizutani Y, Kakushima N, Ishikawa T, Furukawa K, Ohno E, Honda T, Kawashima H, Ishigami M, Furune S, Hase T, Yokota K, Maeda O, Hashimoto N, Akiyama M, Ando Y, Fujishiro M. Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival. World J Gastroenterol 2021; 27(41): 7190-7206 [PMID: 34887637 DOI: 10.3748/wjg.v27.i41.7190]
URL:	https://www.wjgnet.com/1007-9327/full/v27/i41/7190.htm

For:

Yamada K, Sawada T, Nakamura M, Yamamura T, Maeda K, Ishikawa E, Iida T, Mizutani Y, Kakushima N, Ishikawa T, Furukawa K, Ohno E, Honda T, Kawashima H, Ishigami M, Furune S, Hase T, Yokota K, Maeda O, Hashimoto N, Akiyama M, Ando Y, Fujishiro M. Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival. World J Gastroenterol 2021; 27(41): 7190-7206 [PMID: 34887637 DOI: 10.3748/wjg.v27.i41.7190]

URL:

https://www.wjgnet.com/1007-9327/full/v27/i41/7190.htm

(220) (203) (0) (0) (0) (1) (6974) (24)

Number	Citing Articles
1	Guihong Wan, Wenxin Chen, Sara Khattab, Katie Roster, Nga Nguyen, Boshen Yan, Ahmad Rajeh, Jayhyun Seo, Hannah Rashdan, Leyre Zubiri, Matthew J Hadfield, Shadmehr Demehri, Kun-Hsing Yu, William Lotter, Alexander Gusev, Nicole R LeBoeuf, Kerry L Reynolds, Shawn G Kwatra, Yevgeniy R Semenov. Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study. The Lancet Oncology 2024; 25(8) doi: 10.1016/S1470-2045(24)00278-X
2	Emir Cerme, Murad Guliyev, Vali Aliyev, Zeliha Birsin, Murat Günaltılı, Mehmet Cem Fidan, Selin Cebeci, Seda Jeral, Hamza Abbasov, Nebi Serkan Demirci, Ozkan Alan. Immune-Mediated upper gastrointestinal toxicities reported With immune checkpoint inhibitors: An analysis of the food and drug administration adverse event reporting system (FAERS). Journal of Oncology Pharmacy Practice 2026; doi: 10.1177/10781552261447836
3	Kristian C. Williams, Abigail Gault, Amy E. Anderson, Christopher J. Stewart, Christopher A. Lamb, R. Ally Speight, Neil Rajan, Ruth Plummer, Arthur G. Pratt. Immune-related adverse events in checkpoint blockade: Observations from human tissue and therapeutic considerations. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1122430
4	Li Na Feng, Jin He, Li Xia Feng, Yan Li, Juan Li, Chen Chen. Symptoms, symptom clusters and associated factors among cancer patients receiving immune checkpoint inhibitor therapy: A cross-sectional survey. European Journal of Oncology Nursing 2023; 63 doi: 10.1016/j.ejon.2023.102288
5	Mc Neil Valencia, Zeeshan Abbas, Seung Won Lee. Efficacy and adverse events of immune checkpoint inhibitors: evidence from non-small cell lung cancer and gastric cancer in Korea and Japan. Precision and Future Medicine 2025; 9(1) doi: 10.23838/pfm.2025.00009
6	Qinan Yin, Liuyun Wu, Lizhu Han, Xingyue Zheng, Rongsheng Tong, Lian Li, Lan Bai, Yuan Bian. Immune-related adverse events of immune checkpoint inhibitors: a review. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1167975
7	Grigorios Petrousis, Sylwester Szczegielniak, Haider Sabhan, Peter Elbe, Gülden Bilican, Hans Strid, Francesca Bresso, Charlotte Hedin, Stephan L Haas. Endoscopic insights into digestive-related adverse effects of immune checkpoint inhibitors: A narrative review. World Journal of Gastrointestinal Endoscopy 2025; 17(7): 107798 doi: 10.4253/wjge.v17.i7.107798 Abstract(262) \| Core Tip(249) \| Full Article(HTML)(1113) \| Full Article (PDF)-5765K(132) \| Full Article with Cover (PDF)-6101K(141) \| Full Article (XML)-237K(76) \| Audio-2106K(15) \| Peer-Review Report-179K(63) \| Answering Reviewers-73K(64) \| Times Cited (1) \| Total Visits (1802) \| Open
8	Yu Chen, Shi-Cheng Zheng, Zhong-Qiao Lin, Jing Lin. Immune checkpoint inhibitor-associated gastritis: Patterns and management. World Journal of Gastroenterology 2024; 30(14): 1941-1948 doi: 10.3748/wjg.v30.i14.1941 Abstract(745) \| Core Tip(790) \| Full Article(HTML)(5678) \| Full Article (PDF)-413K(371) \| Full Article with Cover (PDF)-709K(228) \| Full Article (XML)-160K(171) \| Audio-1549K(32) \| Peer-Review Report-220K(151) \| Answering Reviewers-149K(150) \| Times Cited (10) \| Total Visits (6448) \| Open
9	Mina Hosseini, Nima Rezaei. Lung Cancer Diagnosis and Treatment: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2022; 9 doi: 10.1007/16833_2022_52
10	Qian Sun, Hongyan Sun, Nan Wu, Yue Hu, Fangqing Zhang, Xianling Cong. Patients with melanoma treated with immune checkpoint inhibitors who had non-thyroid endocrine and skin immune-related adverse events have better prognosis: A systematic review and meta-analysis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.976224
11	E. R. Zagidullina, V. B. Kaliberdenko, E. R. Kulieva, V. S. Beter, T. S. Pronkina, V. A. Kushner, V. V. Taran. Adverse reactions of immune checkpoint inhibitors. Medical Immunology (Russia) 2025; 27(3) doi: 10.15789/1563-0625-ARO-3191
12	Nozomi Sano, Atsushi Naganuma, Kenta Ido, Hiroaki Naruse, Yuhei Suzuki, Tomoyuki Masuda, Takashi Hoshino, Hidetoshi Yasuoka, Toshio Uraoka, Satoru Kakizaki. Cytomegalovirus gastritis following immune checkpoint inhibitor-associated gastritis induced by ipilimumab and nivolumab therapy in a patient with renal cell carcinoma. Clinical Journal of Gastroenterology 2026; 19(2) doi: 10.1007/s12328-026-02290-8
13	G. Wang, J. Qin, W. Nong, D. Ma, C. Wang, H. Yu, S. Tang, M. Chen, J. Gao, T. Gao, L. Li, K. Hu, P. Yang, Q. Qiu, S. Qu. Consensus statement on the multidisciplinary treatment of nasopharyngeal carcinoma with immune checkpoint inhibitors in China. ESMO Open 2025; 10(9) doi: 10.1016/j.esmoop.2025.105763
14	Shoichiro Hirata, Yoshiyasu Kono, Emi Tanaka, Masahiko Sue, Yasuto Takeuchi, Tomoki Yoshikawa, Yoshie Maki, Tomohiro Kamio, Daisuke Kametaka, Katsunori Matsueda, Chihiro Sakaguchi, Kenta Hamada, Masaya Iwamuro, Seiji Kawano, Yoshiro Kawahara, Motoyuki Otsuka. Prognostic Impact of Gastrointestinal Immune-Related Adverse Events Depends on Nutritional Status in Cancer Patients Treated with Immune Checkpoint Inhibitors. Cancers 2025; 17(16) doi: 10.3390/cancers17162634
15	Sae Ohwada, Keisuke Ishigami, Noriyuki Akutsu, Hiroshi Nakase. Pharmacological Treatments Available for Immune-Checkpoint-Inhibitor-Induced Colitis. Biomedicines 2022; 10(6) doi: 10.3390/biomedicines10061334
16	Jing Wang, Ziyue Guo, Mengyi Shen, Qi Xie, Hongjie Xiang. Potential application mechanism of traditional Chinese medicine in treating immune checkpoint inhibitor-induced colitis. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1366489
17	Takanori Ito, Shigeo Shimose, Joji Tani, Tetsu Tomonari, Issei Saeki, Yasuto Takeuchi, Takeshi Hatanaka, Kyo Sasaki, Satoru Kakizaki, Yuki Kanayama, Naoki Yoshioka, Takehito Naito, Mamiko Takeuchi, Tetsuya Yasunaka, Masahiro Sakata, Hideki Iwamoto, Satoshi Itano, Tomotake Shirono, Norikazu Tanabe, Takafumi Yamamoto, Atsushi Naganuma, Sohji Nishina, Motoyuki Otsuka, Taro Takami, Tetsuji Takayama, Takumi Kawaguchi, Hiroki Kawashima. Antitumor effects and immune‐mediated adverse events of durvalumab plus tremelimumab treatment for unresectable hepatocellular carcinoma. Hepatology Research 2025; 55(4) doi: 10.1111/hepr.14151
18	Taito Fukushima, Satoshi Kobayashi, Makoto Ueno. The correlation between immune-related adverse events and efficacy of immune checkpoint inhibitors. Japanese Journal of Clinical Oncology 2024; 54(9) doi: 10.1093/jjco/hyae067
19	Shusu Liu, Peiyu Lu, Bixia Yang, Yan Yang, Hua Zhou, Min Yang. Single-cell RNA sequencing analysis of peripheral blood mononuclear cells in PD-1-induced renal toxicity in patients with lung cancer. BMC Nephrology 2024; 25(1) doi: 10.1186/s12882-024-03754-0
20	Junying Pan, Liying Yang, Haoyu Wang, Yinghua Chen. Mechanisms of traditional Chinese medicine in enhancing the efficacy and reducing the toxicity of immune checkpoint inhibitors via regulation of the tumor microenvironment and gut microbiota . Journal of Enzyme Inhibition and Medicinal Chemistry 2026; 41(1) doi: 10.1080/14756366.2026.2662446
21	Longcong Dong, Ruibin Zhang, Qin Huang, Yuan Shen, Hongying Li, Shuguang Yu, Qiaofeng Wu. Construction, bioinformatics analysis, and validation of competitive endogenous RNA networks in ulcerative colitis. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.951243
22	Hao Wen, Yange Qi, Jianbo Song, Xia Yan. Single-cell transcriptomic insights into the immune heterogeneity of immune checkpoint inhibitors related organ toxicities. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1823949
23	Miguel A. Galindo-Campos, Max Hardy-Werbin, Joan Gibert, Margherita Pucci, Anna Hernández-Prat, Alejandro Ríos-Hoyo, Pedro Rocha, Adriá Rossell, Raúl del Rey-Vergara, Ana Parreira, Andrés Pellicer, Álvaro Taus, Ana Rovira, Edurne Arriola. Peripheral immune cell subsets as potential predictors of benefit from immune checkpoint blockade therapy in small cell lung cancer. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1802274
24	Noelia Silva-Pilipich, Ángela Covo-Vergara, Cristian Smerdou. Local Delivery of Immunomodulatory Antibodies for Gastrointestinal Tumors. Cancers 2023; 15(8) doi: 10.3390/cancers15082352
25	Michail C. Papazoglou, Chrysostomos Avgeros, Eleni Sogka, Anestis Chrysostomidis, Georgios Karakinaris, Anastasios Boutis, Aimilios Lallas, Athanassios Kyrgidis. Clinical, Dermatoscopic, Histological and Molecular Prognostic and Predictive Factors of Metastatic Melanoma Response to Immunotherapy: A Systematic Review and Drug Class Meta-Analysis. Journal of Clinical Medicine 2026; 15(6) doi: 10.3390/jcm15062145